ArticleStem cell reviews and reports2025

Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up.

Min Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.